Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGFR | P43088 | 15/20 | 0.67 |
| ▸ | PTGER3 | P43115 | 7/20 | 0.67 |
| ▸ | TBXA2R | P21731 | 4/20 | 0.67 |
| ▸ | PTGER1 | P34995 | 3/20 | 0.67 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.48 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.48 |
| ▸ | SLCO2A1 | Q92959 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Etiproston SCHEMBL11602088 | 1.00 | PTGFR (0.67) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| Etiproston SCHEMBL12495605 | 1.00 | PTGFR (0.67) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| Etiproston SCHEMBL11603831 | 1.00 | PTGFR (0.67) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| Etiproston SCHEMBL571117 | 1.00 | PTGFR (0.67) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| Etiproston SCHEMBL11602481 | 1.00 | PTGFR (0.67) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| Etiproston SCHEMBL572165 | 0.94 | PTGFR (0.60) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| SCHEMBL11602885 | 0.92 | PTGFR (0.57) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| SCHEMBL11601015 | 0.92 | PTGFR (0.57) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| SCHEMBL11602425 | 0.92 | PTGFR (0.57) | PTGFRPTGER3TBXA2RPTGER1THRB | |
| SCHEMBL11602179 | 0.92 | PTGFR (0.57) | PTGFRPTGER3TBXA2RPTGER1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160113942-A1 | COMPOSITIONS COMPRISING A PROSTAGLANDIN FOR TREATING NEUROPSYCHIATRIC CONDITIONS | INCEPTUM RESEARCH & THERAPEUTICS, INC. (CA) | 2016-04-28 | — | — | US | claimed |
| EP-2667875-A1 | COMPOSITIONS COMPRISING A PROSTAGLANDIN FOR TREATING NEUROPSYCHIATRIC CONDITIONS | Inceptum Research & Therapeutics, Inc. (CA) | 2013-12-04 | — | — | EP | claimed |
| US-20130309330-A1 | COMPOSITIONS COMPRISING A PROSTAGLANDIN FOR TREATING NEUROPSYCHIATRIC CONDITIONS | INCEPTUM RESEARCH & THERAPEUTICS, INC. (CA) | 2013-11-21 | — | — | US | claimed |
| WO-2012100347-A1 | COMPOSITIONS COMPRISING A PROSTAGLANDIN FOR TREATING NEUROPSYCHIATRIC CONDITIONS | INCEPTUM RESEARCH & THERAPEUTICS, INC. (CA) | 2012-08-02 | — | — | WO | claimed |
| US-20160113942-A1 | COMPOSITIONS COMPRISING A PROSTAGLANDIN FOR TREATING NEUROPSYCHIATRIC CONDITIONS | INCEPTUM RESEARCH & THERAPEUTICS, INC. (CA) | 2016-04-28 | — | — | US | disclosed |
| US-9259409-B2 | Compositions comprising a prostaglandin for treating neuropsychiatric conditions | INCEPTUM RESEARCH & THERAPEUTICS, INC. (CA) | 2016-02-16 | — | — | US | disclosed |
| EP-2667875-A1 | COMPOSITIONS COMPRISING A PROSTAGLANDIN FOR TREATING NEUROPSYCHIATRIC CONDITIONS | Inceptum Research & Therapeutics, Inc. (CA) | 2013-12-04 | — | — | EP | disclosed |
| US-20130309330-A1 | COMPOSITIONS COMPRISING A PROSTAGLANDIN FOR TREATING NEUROPSYCHIATRIC CONDITIONS | INCEPTUM RESEARCH & THERAPEUTICS, INC. (CA) | 2013-11-21 | — | — | US | disclosed |
| WO-2012100347-A1 | COMPOSITIONS COMPRISING A PROSTAGLANDIN FOR TREATING NEUROPSYCHIATRIC CONDITIONS | INCEPTUM RESEARCH & THERAPEUTICS, INC. (CA) | 2012-08-02 | — | — | WO | disclosed |